RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
93.03%
This Fund
S&P 500
1 Year Est. Return
+93.03%
AUM
$1.7B
AUM Growth
-$252M
(-13%)
Holding
107
Top Buys
| 1 | +$17.4M | |
| 2 | +$15M | |
| 3 | +$9.3M | |
| 4 |
HTFL
Heartflow Inc
HTFL
|
+$8M |
| 5 |
PTC Therapeutics
PTCT
|
+$7.08M |
Top Sells
| 1 | +$61.1M | |
| 2 | +$45.3M | |
| 3 | +$27.4M | |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$24M |
| 5 |
Travere Therapeutics
TVTX
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 99.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vera Therapeutics
VERA
$2.55B
| $20.3M | 1.19% |
503,585
-64,994
|
|
||
27
Neurocrine Biosciences
NBIX
$15.9B
| $19.8M | 1.17% |
150,450
+24,950
|
|
||
|
ACLX
28
DELISTED
Arcellx
ACLX
| $19.5M | 1.15% |
169,859
|
|
||
29
NewAmsterdam Pharma
NAMS
$3.94B
| $18.8M | 1.11% |
588,794
+31,600
|
|
||
30
Pharvaris
PHVS
$2.11B
| $18.2M | 1.07% |
645,533
+22,131
|
|
||
31
Erasca
ERAS
$3.99B
| $17.9M | 1.05% |
1,103,469
+151,759
|
|
||
32
Dyne Therapeutics
DYN
$3.2B
| $17.6M | 1.04% |
972,198
+59,243
|
|
||
33
Compass Therapeutics
CMPX
$429M
| $17.5M | 1.03% |
3,305,308
-621,894
|
|
||
34
Aclaris Therapeutics
ACRS
$635M
| $16.8M | 0.99% |
4,472,650
+18,909
|
|
||
35
Tarsus Pharmaceuticals
TARS
$2.56B
| $15.8M | 0.93% |
225,179
-35,165
|
|
||
|
MMED
36
MiniMed Group Inc
MMED
$3.38B
| $15.7M | 0.93% |
+1,055,000
|
|
||
37
Zai Lab
ZLAB
$1.99B
| $15.3M | 0.9% |
814,707
+3,161
|
|
||
38
UnitedHealth
UNH
$345B
| $14.3M | 0.85% |
53,000
+12,200
|
|
||
|
CNTA
39
Centessa Pharmaceuticals
CNTA
$6.15B
| $14M | 0.82% |
351,828
+27,813
|
|
||
|
HTFL
40
Heartflow Inc
HTFL
$2.67B
| $13.9M | 0.82% |
572,500
+294,800
|
|
||
41
Ardelyx
ARDX
$1.49B
| $13.8M | 0.81% |
2,299,473
|
|
||
42
Summit Therapeutics
SMMT
$13.6B
| $13.5M | 0.79% |
710,000
|
|
||
43
Azenta
AZTA
$1.05B
| $12M | 0.71% |
569,100
|
|
||
44
Mineralys Therapeutics
MLYS
$2.6B
| $11.9M | 0.7% |
439,751
+12,155
|
|
||
45
Danaher
DHR
$129B
| $11.7M | 0.69% |
61,500
|
|
||
|
46
PTC Therapeutics
PTCT
$6.13B
| $11M | 0.65% |
161,798
+99,919
|
|
||
|
CAI
47
Caris Life Sciences
CAI
$4.73B
| $10.1M | 0.59% |
563,000
-124,500
|
|
||
|
ZBIO
48
Zenas BioPharma
ZBIO
$1.16B
| $9.82M | 0.58% |
502,077
|
|
||
|
BCAX
49
Bicara Therapeutics
BCAX
$1.43B
| $9.73M | 0.57% |
489,095
+60,000
|
|
||
50
BridgeBio Pharma
BBIO
$13B
| $9.52M | 0.56% |
128,250
+24,750
|
|